Research graph
References from Targeted delivery of the CB 2 receptor agonist JWH‐133 via VCAM‐1‐functionalised nanoparticles attenuates atherosclerosis and reveals sex‐specific therapeutic outcomes. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41371-019-0273-0
10.1038/s41371-019-0273-0 · External reference
10.1038/s41419-024-07166-8
10.1038/s41419-024-07166-8 · External reference
10.1111/bph.70230
10.1111/bph.70230 · External reference
10.1111/bph.70234
10.1111/bph.70234 · External reference
10.1111/bph.70235
10.1111/bph.70235 · External reference
10.1161/jaha.118.009099
10.1161/jaha.118.009099 · External reference
10.1016/j.nano.2017.07.010
10.1016/j.nano.2017.07.010 · External reference
10.1152/ajpheart.00217.2016
10.1152/ajpheart.00217.2016 · External reference
10.1038/npp.2017.140
10.1038/npp.2017.140 · External reference
10.1111/bph.17441
10.1111/bph.17441 · External reference
10.1007/978-3-030-57456-7_13
10.1007/978-3-030-57456-7_13 · 2021 · External reference
10.1021/acsnano.5c00216
10.1021/acsnano.5c00216 · External reference
10.1038/s41598-022-05301-z
10.1038/s41598-022-05301-z · External reference
10.1002/jbm.a.37916
10.1002/jbm.a.37916 · External reference
Development of enhanced drug delivery vehicles for three cannabis‐based terpenes using poly (lactic‐co‐glycolic acid) based nanoparticles
10.1016/j.indcrop.2021.113345 · 2021 · External reference
10.3390/pharmaceutics12050439
10.3390/pharmaceutics12050439 · External reference
10.3390/pharmaceutics11080391
10.3390/pharmaceutics11080391 · External reference
10.1093/eurheartj/ehab551
10.1093/eurheartj/ehab551 · External reference
10.1016/j.biopha.2021.111639
10.1016/j.biopha.2021.111639 · External reference
10.1016/j.yjmcc.2011.08.008
10.1016/j.yjmcc.2011.08.008 · External reference
10.1016/j.ijbiomac.2022.04.209
10.1016/j.ijbiomac.2022.04.209 · External reference
10.1021/acs.jafc.0c07251
10.1021/acs.jafc.0c07251 · External reference
10.1016/s0968-0896(99)00219-9
10.1016/s0968-0896(99)00219-9 · External reference
10.1016/j.vaccine.2023.06.009
10.1016/j.vaccine.2023.06.009 · External reference
10.3390/antiox15010119
10.3390/antiox15010119 · External reference
10.1038/s41586-021-03392-8
10.1038/s41586-021-03392-8 · External reference
10.1111/bph.15178
10.1111/bph.15178 · External reference
10.1016/j.jconrel.2025.02.001
10.1016/j.jconrel.2025.02.001 · External reference
10.1016/j.atherosclerosis.2023.04.005
10.1016/j.atherosclerosis.2023.04.005 · External reference
10.1111/j.1365-2826.2008.01685.x
10.1111/j.1365-2826.2008.01685.x · External reference
10.1161/circresaha.120.315930
10.1161/circresaha.120.315930 · External reference
10.1016/j.colsurfb.2014.09.002
10.1016/j.colsurfb.2014.09.002 · External reference
10.1016/j.ijpharm.2015.04.054
10.1016/j.ijpharm.2015.04.054 · External reference
10.1016/j.jconrel.2018.03.002
10.1016/j.jconrel.2018.03.002 · External reference
10.1016/j.colsurfb.2025.115057
10.1016/j.colsurfb.2025.115057 · External reference
10.1007/s11883-024-01259-7
10.1007/s11883-024-01259-7 · External reference
10.1093/eurheartj/ehr449
10.1093/eurheartj/ehr449 · External reference
10.2174/1381612827666210122142811
10.2174/1381612827666210122142811 · External reference
10.1007/s11906-020-01112-7
10.1007/s11906-020-01112-7 · External reference
10.1016/j.addr.2020.10.006
10.1016/j.addr.2020.10.006 · External reference
RKinetDS: A flexible open‐source software for modeling dissolution profiles
10.14227/dt330126p20 · 2026 · External reference
10.1016/j.plipres.2011.01.001
10.1016/j.plipres.2011.01.001 · External reference
10.1038/nrcardio.2017.130
10.1038/nrcardio.2017.130 · External reference
10.3389/fbioe.2022.882363
10.3389/fbioe.2022.882363 · External reference
10.1007/978-3-030-83395-4_14
10.1007/978-3-030-83395-4_14 · 2022 · External reference
10.1016/j.abb.2020.108453
10.1016/j.abb.2020.108453 · External reference
10.1371/journal.pbio.3000410
10.1371/journal.pbio.3000410 · External reference
10.1016/j.jff.2016.08.037
10.1016/j.jff.2016.08.037 · External reference
10.1016/j.nut.2016.12.005
10.1016/j.nut.2016.12.005 · External reference
10.1007/s00394-015-1074-z
10.1007/s00394-015-1074-z · External reference
10.1016/j.atherosclerosis.2016.04.023
10.1016/j.atherosclerosis.2016.04.023 · External reference
10.3390/ijms242417516
10.3390/ijms242417516 · External reference
10.1021/acsptsci.9b00049
10.1021/acsptsci.9b00049 · External reference
10.1038/srep12931
10.1038/srep12931 · External reference
10.26828/cannabis/2024/000206
10.26828/cannabis/2024/000206 · External reference
10.1038/s41573-021-00198-1
10.1038/s41573-021-00198-1 · External reference
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off‐target activity
10.1038/ncomms13958 · 2017 · External reference
Vcam‐1 target in non‐invasive imaging for the detection of atherosclerotic plaques
2020 · External reference
Targeting VCAM‐1: A therapeutic opportunity for vascular damage
10.1080/14728222.2023.2187778 · 2023 · External reference
10.3389/fcvm.2021.707889
10.3389/fcvm.2021.707889 · External reference
10.1016/j.mvr.2020.104077
10.1016/j.mvr.2020.104077 · External reference
10.1208/s12249-024-02836-4
10.1208/s12249-024-02836-4 · External reference
10.1002/wnan.70057
10.1002/wnan.70057 · External reference
Unresolved reference
2021 · External reference
10.1016/j.lfs.2020.118424
10.1016/j.lfs.2020.118424 · External reference
10.1039/d2ra05661e
10.1039/d2ra05661e · External reference
10.1016/j.apsb.2024.08.006
10.1016/j.apsb.2024.08.006 · External reference
10.3389/fphar.2022.825459
10.3389/fphar.2022.825459 · External reference
10.3390/molecules28134991
10.3390/molecules28134991 · External reference
10.1186/s12951-025-03436-5
10.1186/s12951-025-03436-5 · External reference
